Literature DB >> 13342471

Hyperthyroidism developing during P.A.S. therapy.

S TANDHANAND, R BURI.   

Abstract

Entities:  

Keywords:  HYPERTHYROIDISM/etiology and pathogenesis; PARA-AMINOSALICYLIC ACID/injurious effects; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1956        PMID: 13342471      PMCID: PMC2034979          DOI: 10.1136/bmj.2.4987.281

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  The direct antithyroid action of para-aminosalicylic acid and isoniazid.

Authors:  R W ANGEL; S W MAYER; M E MORTON
Journal:  Am Rev Tuberc       Date:  1955-06

2.  The goitrogenic effect of para-aminosalicylic acid during the therapy of pulmonary tuberculosis; report of eleven cases.

Authors:  G L BRINKMAN; E O COATES
Journal:  Am Rev Tuberc       Date:  1954-03

3.  Radio-iodine measurements of thyroid function during and after P.A.S. treatment of tuberculosis.

Authors:  J A BALINT; R FRASER; M G HANNO
Journal:  Br Med J       Date:  1954-05-29

4.  Goitre and hypothyroidism developing during treatment with P.A.S.

Authors:  H T DAVIES; H J B GALBRAITH
Journal:  Br Med J       Date:  1953-06-06

5.  A case of myxoedema developing during p-aminosalicylic acid therapy.

Authors:  G M KOMROWER
Journal:  Br Med J       Date:  1951-11-17

6.  Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid.

Authors:  N BERGQVIST; O DE MARE
Journal:  Acta Med Scand       Date:  1952-08-05

7.  [Artificial myxedema during para-aminosalicylic acid therapy].

Authors:  K H CLAUSEN; K KJERULF-JENSEN
Journal:  Nord Med       Date:  1951-03-28

8.  Paraaminosalicylic acid in tuberculosis; clinical and pharmacological aspects.

Authors:  D G MADIGAN; L L GRIFFITHS
Journal:  Lancet       Date:  1950-02-11       Impact factor: 79.321

  8 in total
  1 in total

1.  The hypersensitivity reactions to para-aminosalicylic acid (P.A.S.).

Authors:  S CARNE
Journal:  Arch Dis Child       Date:  1957-10       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.